DAVENPORT & Co LLC reduced its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 3.3% in the fourth quarter, ...

Chicago Partners Investment Group LLC bought a new stake in shares of Novartis AG (NYSE:NVS – Free Report) during the 4th ...

The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark ...

Novartis AG (NYSE:NVS), a global healthcare powerhouse with a market capitalization of $208.27 billion, has recently transformed into a pure-play pharmaceutical company, sharpening its focus on its ...

Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...

Novartis AG (NVS) reports robust financial performance with significant product sales growth, while addressing potential ...

UBS analyst Matthew Weston maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of CHF111.00.Maximize ...

Operator instructions] The conference is being recorded. [Operator instructions] A recording of the conference call, ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

Most readers would already be aware that Novartis' (VTX:NOVN) stock increased significantly by 7.9% over the past month.

Valley National Advisers Inc. lowered its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 7.0% during the fourth ...

Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...